经导管瓣膜介入治疗最新进展
Latest Progress of Transcatheter Valve Interventions
09/12 09:30-10:30
主会场·国际场（5楼 水晶厅 -Ⅰ&Ⅳ） (Main Arena - International (5F Crystal Hall - I & IV))
-
09:30-10:30
-
09:30-10:30
-
09:30-10:30学习目标 • 紧跟经导管瓣膜耐久性研究的最新进展 • 认识经导管介入治疗进展如何重塑心脏瓣膜病管理 • 汲取最新突破性临床研究的核心信息Session Objectives • Stay current with the latest progress in transcatheter valve durability • Appreciate how progress in transcatheter valve therapy is reshaping valvular heart disease management • Absorb the key messages from the newest late-breaking trials
-
09:30-09:32
-
09:32-09:42TAVR 瓣膜的耐久性：当代证据与未来展望TAVR valve durability: contemporary evidence and future outlook
-
09:42-09:46讨论与观众互动Discussion and audience interaction
-
09:46-09:56单纯主动脉瓣反流的当代外科治疗Contemporary surgical treatment of pure aortic regurgitation
-
09:56-10:00讨论与观众互动Discussion and audience interaction
-
10:00-10:10TTVR、三尖瓣 TEER 及经导管三尖瓣瓣环成形：个体化治疗选择TTVR versus tricuspid TEER versus transcatheter tricuspid annuloplasty: a patient-tailored treatment algorithm
-
10:10-10:14讨论与观众互动Discussion and audience interaction
-
10:14-10:24二尖瓣与三尖瓣介入的突破性临床试验：经验与待解问题Late-breaking trials in mitral and tricuspid intervention: lessons learned and remaining unknowns
-
10:24-10:28讨论与观众互动Discussion and audience interaction
-
10:28-10:30